Practical Management of CD30⁺ Lymphoproliferative Disorders.

摘要: Primary cutaneous CD30⁺ lymphoproliferative disorders (LPDs) account for approximately 25% of lymphomas. Although these LPDs are clinically heterogeneous, they can be indistinguishable histologically. Lymphomatoid papulosis rarely requires systemic treatment; however, multifocal primary anaplastic large cell lymphoma and transformation mycosis fungoides typically treated systemically. As rare, there is little published evidence to support a specific treatment algorithm. Most studies case reports, small series, or retrospective reviews. This article discusses various choices each the offers practical pearls aid in choosing an appropriate regimen.